Immunology

  1. Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain

    1. Gabriele Cerutti
    2. Yicheng Guo
    3. Pengfei Wang
    4. Manoj S. Nair
    5. Maple Wang
    6. Yaoxing Huang
    7. Jian Yu
    8. Lihong Liu
    9. Phinikoula S. Katsamba
    10. Fabiana Bahna
    11. Eswar R. Reddem
    12. Peter D. Kwong
    13. David D. Ho
    14. Zizhang Sheng
    15. Lawrence Shapiro

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Binding of phosphatidylserine‐positive microparticles by PBMCs classifies disease severity in COVID‐19 patients

    1. Lisa Rausch
    2. Konstantin Lutz
    3. Martina Schifferer
    4. Elena Winheim
    5. Rudi Gruber
    6. Elina F. Oesterhaus
    7. Linus Rinke
    8. Johannes C. Hellmuth
    9. Clemens Scherer
    10. Maximilian Muenchhoff
    11. Christopher Mandel
    12. Michael Bergwelt‐Baildon
    13. Mikael Simons
    14. Tobias Straub
    15. Anne B. Krug
    16. Jan Kranich
    17. Thomas Brocker

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. The percentage of Monocytes CD39+ is higher in Pregnant COVID-19 than in Non-Pregnant COVID-19 patients

    1. A. Cérbulo-Vázquez
    2. M. García-Espinosa
    3. J.C. Briones-Garduño
    4. L. Arriaga-Pizano
    5. E. Ferat-Osorio
    6. B. Zavala-Barrios
    7. G.L. Cabrera-Rivera
    8. P. Miranda-Cruz
    9. M.T. García de la Rosa
    10. J.L. Prieto-Chávez
    11. V. Rivero-Arredondo
    12. R.L. Madera-Sandoval
    13. A. Cruz-Cruz
    14. E. Salazar-Rios
    15. ME Salazar-Rios
    16. D Serrano-Molina
    17. R. C. De Lira-Barraza
    18. A. H. Villanueva-Compean
    19. A. Esquivel-Pineda
    20. R. Ramirez-Montes de Oca
    21. F. Caldiño-Soto
    22. L.A. Ramírez-García
    23. G. Flores-Padilla
    24. O. Moreno-Álvarez
    25. GML Guerrero-Avendaño
    26. C. López-Macías

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2

    1. Takahiro Kageyama
    2. Shigeru Tanaka
    3. Keishi Etori
    4. Koto Hattori
    5. Kazusa Miyachi
    6. Tadamichi Kasuya
    7. Taro Iwamoto
    8. Kei Ikeda
    9. Hidetoshi Igari
    10. Koutaro Yokote
    11. Hiroshi Nakajima

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Rapid determination of the wide dynamic range of SARS-CoV-2 Spike T cell responses in whole blood of vaccinated and naturally infected

    1. Anthony T Tan
    2. Joey Ming Er Lim
    3. Nina Le Bert
    4. Kamini Kunasegaran
    5. Adeline Chia
    6. Martin Daniel Co Qui
    7. Nicole Tan
    8. Wan Ni Chia
    9. Ruklanthi de Alwis
    10. Ding Ying
    11. Eng Eong Ooi
    12. Lin-Fa Wang
    13. Mark I-Cheng Chen
    14. Barnaby Young
    15. Li Yang Hsu
    16. Jenny GH Low
    17. David Chien Lye
    18. Antonio Bertoletti

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants

    1. Linglei Jiang
    2. Tom A.P. Driedonks
    3. Wouter S.P. Jong
    4. Santosh Dhakal
    5. H. Bart van den Berg van Saparoea
    6. Ioannis Sitaras
    7. Ruifeng Zhou
    8. Christopher Caputo
    9. Kirsten Littlefield
    10. Maggie Lowman
    11. Mengfei Chen
    12. Gabriela Lima
    13. Olesia Gololobova
    14. Barbara Smith
    15. Vasiliki Mahairaki
    16. M. Riley Richardson
    17. Kathleen R. Mulka
    18. Andrew P. Lane
    19. Sabra L. Klein
    20. Andrew Pekosz
    21. Cory Brayton
    22. Joseph L. Mankowski
    23. Joen Luirink
    24. Jason S. Villano
    25. Kenneth W. Witwer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2

    1. Dhiraj K. Singh
    2. Ekaterina Aladyeva
    3. Shibali Das
    4. Bindu Singh
    5. Ekaterina Esaulova
    6. Amanda Swain
    7. Mushtaq Ahmed
    8. Journey Cole
    9. Chivonne Moodley
    10. Smriti Mehra
    11. Larry S. Schlesinger
    12. Maxim N. Artyomov
    13. Shabaana A. Khader
    14. Deepak Kaushal

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. SARS-CoV-2 spike RBD and nucleocapsid encoding DNA vaccine elicits T cell and neutralising antibody responses that cross react with variants

    1. VA Brentville
    2. M Vankemmelbeke
    3. RL Metheringham
    4. P Symonds
    5. KW Cook
    6. RA Urbanowicz
    7. T Tsoleridis
    8. CM Coleman
    9. K-C Chang
    10. A Skinner
    11. E Dubinina
    12. I Daniels
    13. S Shah
    14. M Argonza
    15. J Delgado
    16. V Dwivedi
    17. V Kulkarni
    18. JE Dixon
    19. AG Pockley
    20. SE Adams
    21. SJ Paston
    22. JM Daly
    23. JK Ball
    24. LG Durrant

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines

    1. José G. Montoya
    2. Amy E. Adams
    3. Valérie Bonetti
    4. Sien Deng
    5. Nan A. Link
    6. Suzanne Pertsch
    7. Kjerstie Olson
    8. Martina Li
    9. Ellis C. Dillon
    10. Dominick L. Frosch

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses

    1. Victor Yin
    2. Szu-Hsueh Lai
    3. Tom G. Caniels
    4. Philip J. M. Brouwer
    5. Mitch Brinkkemper
    6. Yoann Aldon
    7. Hejun Liu
    8. Meng Yuan
    9. Ian A. Wilson
    10. Rogier W. Sanders
    11. Marit J. van Gils
    12. Albert J. R. Heck

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 107 of 174 Next